Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05033275 · ClinicalTrials.gov registry record
Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy
A clinical trial, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- 60
- Enrollment target
NCT05033275: Clinical Trial study, sponsored by University of Missouri-Columbia.
NCT05033275 is a clinical trial that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05033275 was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Babies born to mothers with pregestational diabetes will be screened with parental consent for sacral agenesis
Primary Outcome
All babies who have tethered cord on spinal US will be referred to neurosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2024-12-31 |
Why NCT05033275 stopped before completion
NCT05033275 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05033275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05033275 about?
NCT05033275 is a clinical study titled "Screening for Sacral Agenesis in Offspring of Mothers With Diabetes in Pregnancy". Babies born to mothers with pregestational diabetes will be screened with parental consent for sacral agenesis
What is the current status of trial NCT05033275?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2021-05-01. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT05033275?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI